Editorial: CNS Autoimmune Disorders and COVID-19

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Apr 21

PMID 37082445

Authors

Omid Mirmosayyeb

Shervin Badihian

Vahid Shaygannejad

Hans-Peter Hartung

Affiliations

Soon will be listed here.

References

Beghi E, Giussani G, Westenberg E, Allegri R, Garcia-Azorin D, Guekht A . Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol. 2021; 269(5):2265-2274. PMC: 8528941. DOI: 10.1007/s00415-021-10848-4. View

McAlpine L, Fesharaki-Zadeh A, Spudich S . Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?. Curr Opin Psychiatry. 2021; 34(2):177-185. PMC: 7924921. DOI: 10.1097/YCO.0000000000000688. View

Arbel R, Sergienko R, Friger M, Peretz A, Beckenstein T, Yaron S . Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years. Nat Med. 2022; 28(7):1486-1490. DOI: 10.1038/s41591-022-01832-0. View

Shapiro Ben David S, Baruch Gez S, Rahamim-Cohen D, Shamir-Stein N, Lerner U, Ekka Zohar A . Immediate side effects of Comirnaty COVID-19 vaccine: A nationwide survey of vaccinated people in Israel, December 2020 to March 2021. Euro Surveill. 2022; 27(13). PMC: 8973016. DOI: 10.2807/1560-7917.ES.2022.27.13.2100540. View

Stoian A, Stoian M, Bajko Z, Maier S, Andone S, Cioflinc R . Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature. Biomedicines. 2022; 10(4). PMC: 9024859. DOI: 10.3390/biomedicines10040774. View

Mirmosayyeb O, Ghaffary E, Vaheb S, Pourkazemi R, Shaygannejad V . Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review. Rev Neurol (Paris). 2023; 179(4):265-281. PMC: 9844421. DOI: 10.1016/j.neurol.2022.11.004. View

Sakibuzzaman M, Hassan A, Hayee S, Haque F, Bushra S, Maliha M . Exacerbation of Pre-existing Neurological Symptoms With COVID-19 in Patients With Chronic Neurological Diseases: An Updated Systematic Review. Cureus. 2022; 14(9):e29297. PMC: 9578565. DOI: 10.7759/cureus.29297. View

Ortiz-Prado E, Simbana-Rivera K, Gomez-Barreno L, Rubio-Neira M, Guaman L, Kyriakidis N . Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020; 98(1):115094. PMC: 7260568. DOI: 10.1016/j.diagmicrobio.2020.115094. View

Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K . Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020; 194:105921. PMC: 7227498. DOI: 10.1016/j.clineuro.2020.105921. View

10.

Bhagavati S . Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy. Front Neurol. 2021; 12:664664. PMC: 8079742. DOI: 10.3389/fneur.2021.664664. View

11.

Sampaio Rocha-Filho P, Magalhaes J . Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia. Cephalalgia. 2020; 40(13):1443-1451. PMC: 7645592. DOI: 10.1177/0333102420966770. View

12.

Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E . Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021; 373:n1088. PMC: 8116636. DOI: 10.1136/bmj.n1088. View

13.

Sriwastava S, Kataria S, Tandon M, Patel J, Patel R, Jowkar A . Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series. J Neurol Sci. 2020; 420:117263. PMC: 7725056. DOI: 10.1016/j.jns.2020.117263. View

14.

Mirmosayyeb O, Moases Ghaffary E, Bagherieh S, Barzegar M, Dehghan M, Shaygannejad V . Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review. Mult Scler Relat Disord. 2022; 60:103697. DOI: 10.1016/j.msard.2022.103697. View